Switzerland claimed the #1 position in the WIPO Global Innovation Index 2025 with a score of 66.0, extending an unbroken streak dating back to 2011. Sweden (62.6) and the United States (61.7) trailed by meaningful margins.

Haute Capital Partners SA (BX Swiss: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in BioCopy AG (biocopy.com), a Swiss research-based biotechnology company headquartered in Basel, as part of the company’s capital increase.

Haute Capital Partners SA (BX Swiss: HAUTE) announces that Marcel Aellen is stepping down from the Board of Directors to retire, after several years of dedicated service.

Haute Capital Partners SA (BX Swiss: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in CARE (care.me), a leading AI-powered preventive health platform headquartered in Switzerland, as part of its Pre Series A 2026 funding round.